Abstracts by Namita Chittoria:
Association of time from definitive therapy (DT) to start of androgen deprivation therapy (ADT) for metastatic disease and survival outcomes in men with new metastatic hormone-sensitive prostate cancer (mHSPC).Meeting: 2017 Genitourinary Cancers Symposium | Abstract No: 265
Impact of prior definitive therapy on survival outcomes in men with new hormone-sensitive metastatic prostate cancer (mHSPC).Meeting: 2016 ASCO Annual Meeting | Abstract No: 5083
A phase II study of intermittent sunitinib (S) in previously untreated patients (pts) with metastatic renal cell carcinoma (mRCC).Meeting: 2013 ASCO Annual Meeting | Abstract No: 4515
Outcome of metastatic sarcomatoid renal cell carcinoma (sRCC): Results from the International mRCC Database Consortium.Meeting: 2013 ASCO Annual Meeting | Abstract No: 4565
- Page 0
Click on the title above to search via PubMed.
Speaker pages are intended to connect and list abstracts, presentations and articles to authors of similar names, for your convenience. They are not intended to be a comprehensive list of authored work. ASCO sources currently utilized to create this list are meeting abstracts, virtual meeting presentations, and Educational Book articles. As additional sources are added the source list will be updated.
A speaker's name can be listed differently among various sources (i.e. J.P. Smith and John P. Smith). Authored work under a dissimilar name (nickname, abbreviations, or different spelling) will not be listed together.